Date: Jan 05, 2013 Author: press release Source: proactiveinvestors.com (
click here to go to the source)
San Diego, CA January 8, 2013 -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO, will speak at the 6th Annual OneMedForum San Francisco 2013, to be held at The Sir Francis Drake Hotel on January 8, 2013 at 2:10pm.
Ms. Williams, a cliniCAl diagnostics industry veteran, will discuss the innovative Ridge technology for diagnosing Major Depressive Disorder from blood samples, and the expansion of the company's cliniCAl program for a test to predict antidepressant drug response.
For the first time, blood tests provide clinicians and patients with objective, biologiCAlly-based diagnostic information to manage and treat depression. The blood test results are intended to augment the current tools used for neuropsychiatric diagnosis, therapy selection and patient management.
Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The testing services are provided by the Ridge owned CLIA laboratory. The company is loCAted in San Diego, CA and Research Triangle Park, NC. www.ridgex.com
Contacts:
Ridge Diagnostics: Lonna J Williams, CEO
800-578-7818 ex 101
lwilliams@ridgedx.com
www.onemedplace.com/forum/
Ridge Diagnostics, Inc. to Present on Blood Tests for Depression at OneMedForum
San Diego, CA January 8, 2013 -- Ridge Diagnostics, Inc., a neurodiagnostic company,
announced that Lonna J. Williams, CEO, will speak at the 6th Annual OneMedForum San
Francisco 2013, to be held at The Sir Francis Drake Hotel on January 8, 2013 at 2:10pm.
Ms. Williams, a cliniCAl diagnostics industry veteran, will discuss the innovative Ridge
technology for diagnosing Major Depressive Disorder from blood samples, and the expansion of
the company's cliniCAl program for a test to predict antidepressant drug response.
For the first time, blood tests provide clinicians and patients with objective, biologiCAlly-based
diagnostic information to manage and treat depression. The blood test results are intended to
augment the current tools used for neuropsychiatric diagnosis, therapy selection and patient
management.
Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and
marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has
commercialized the first-in-class, proprietary blood test for the diagnosis and treatment
monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests
are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The
testing services are provided by the Ridge owned CLIA laboratory. The company is loCAted in
San Diego, CA and Research Triangle Park, NC. www.ridgex.com
Contacts:
Ridge Diagnostics: Lonna J Williams, CEO
800-578-7818 ex 101
lwilliams@ridgedx.com
www.onemedplace.com/forum/
